​We seek breakthroughs – innovations that have the power to bring hope for patients with life-altering conditions like cancer and diseases of the heart, immune system, and blood. ​

As a global company with deep connections and strong ties to the communities in which we live, work, and serve, we believe our commitment to global health extends well beyond the discovery, development, and delivery of innovative medicines. We believe that driving long-term business value is at the heart of living our purpose, being leaders and difference-makers for generations to come. Through our Environment, Social and Governance (ESG) strategy we seek to mobilize our capabilities and resources to positively impact our communities.​

We have a rich legacy of addressing health disparities and improving health outcomes for patients around the world. We are committed to making a meaningful impact on today’s global health challenges by ensuring medically underserved and diverse patient populations benefit from inclusive research, innovative medicines and high-quality care and support.​​

With patients at the center of what we do, we partner with organizations who share our values so that together we can deepen our collective understanding of people’s unique challenges and deliver solutions that give hope.​ We support programs, initiatives and organizations that help improve health, expand research opportunities, promote, and expand STEM education and deliver critical services to our communities.​

We will never give up in our search for the next innovation that could mean new hope for patients who are urgently seeking new treatment options today.

Learn more about BMS.

The Bristol Myers Squibb Foundation

The Bristol Myers Squibb Foundation, an independent charitable organization, focuses on communities most at risk of suffering the impacts of serious diseases in regions of the world that are hardest hit. It empowers partners to develop and test innovative solutions to advance health equity and improve access to quality healthcare for patients. Grant making focuses on cancer, cardiovascular disease, and immunologic disease, as well as clinical trial diversity in the United States, and prevalent cancers in nine African countries, Brazil and China.

The mission of the Bristol Myers Squibb Foundation is to promote health equity and improve the health outcomes of populations disproportionately affected by serious diseases by strengthening healthcare worker capacity, integrating medical care and community-based supportive services and mobilizing communities in the fight against disease.

Learn more about the BMS Foundation.